Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Egorin

Showing results (71-80 of 159) with videos related to

Pageof 16
Sort By:
Cancer Research|December 1, 1985
Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinumM J Egorin, D A Van Echo, E A Olman, et al.
Cancer Research|November 15, 1987
Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunctionM J Egorin, B A Conley, A Forrest, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Comparative murine metabolism and disposition of class II anthracycline antibioticsP Dodion, M J Egorin, C E Riggs, et al.
Cancer Research|June 15, 1989
Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)B A Conley, A Forrest, M J Egorin, et al.
Biophysical Chemistry|June 1, 1985
Electron spin resonance of electrochemically generated free radicals from diaziquone and its derivativesP L Gutierrez, B M Fox, M M Mossoba, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamideB A Conley, G F Sewack, M J Egorin, et al.
Life Sciences|September 26, 1983
The plasma pharmacokinetics and tissue distribution of dimethyl sulfoxide in miceT S Kaye, M J Egorin, C E Riggs, et al.
Cancer Research|June 1, 1989
A limited sampling strategy for cyclophosphamide pharmacokineticsM J Egorin, A Forrest, C P Belani, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
In vitro metabolism by mouse and human liver preparations of halomon, an antitumor halogenated monoterpeneM J Egorin, D M Rosen, S E Benjamin, et al.
Cancer Research|June 11, 1998
Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparationsM J Egorin, D M Rosen, J H Wolff, et al.
Pageof 16

Showing results (71-80 of 159) with videos related to

Sort By:
Pageof 16
Cancer Research|December 1, 1985
Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinumM J Egorin, D A Van Echo, E A Olman, et al.
Cancer Research|November 15, 1987
Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunctionM J Egorin, B A Conley, A Forrest, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Comparative murine metabolism and disposition of class II anthracycline antibioticsP Dodion, M J Egorin, C E Riggs, et al.
Cancer Research|June 15, 1989
Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)B A Conley, A Forrest, M J Egorin, et al.
Biophysical Chemistry|June 1, 1985
Electron spin resonance of electrochemically generated free radicals from diaziquone and its derivativesP L Gutierrez, B M Fox, M M Mossoba, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamideB A Conley, G F Sewack, M J Egorin, et al.
Life Sciences|September 26, 1983
The plasma pharmacokinetics and tissue distribution of dimethyl sulfoxide in miceT S Kaye, M J Egorin, C E Riggs, et al.
Cancer Research|June 1, 1989
A limited sampling strategy for cyclophosphamide pharmacokineticsM J Egorin, A Forrest, C P Belani, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
In vitro metabolism by mouse and human liver preparations of halomon, an antitumor halogenated monoterpeneM J Egorin, D M Rosen, S E Benjamin, et al.
Cancer Research|June 11, 1998
Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparationsM J Egorin, D M Rosen, J H Wolff, et al.
Pageof 16